Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2011; 17(26): 3109-3116
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3109
Published online Jul 14, 2011. doi: 10.3748/wjg.v17.i26.3109
Figure 1 CCL20 mRNA expression relative to PMM1 and β2M in colorectal liver metastasis patients with (n = 53) and without (n = 29) FOLFOX chemotherapy before colorectal liver metastasis surgery (A) and itemized according to different time periods of FOLFOX treatment before colorectal liver metastasis surgery (no FOLFOX therapy, n = 29; FOLFOX treatment ≤ 1 mo, n = 14; FOLFOX treatment ≤ 1 year, n = 22; FOLFOX treatment > 1 year, n = 17) (B).
Q-RT-PCR data are expressed as mean ± SE, aP < 0.05 and bP < 0.001, respectively. CRLM: Colorectal liver metastasis.
- Citation: Rubie C, Frick VO, Ghadjar P, Wagner M, Justinger C, Graeber S, Sperling J, Kollmar O, Schilling MK. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. World J Gastroenterol 2011; 17(26): 3109-3116
- URL: https://www.wjgnet.com/1007-9327/full/v17/i26/3109.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i26.3109